|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SUPERCONDUCTOR TECHNOLOGIES INC, 10-Q, EX-10.4, 2000-11-13 |
Next: ENCHIRA BIOTECHNOLOGY CORP, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AT SEPTEMBER 30, 2000 AND THE STATEMENTS OF OPERATIONS FOR THE NINE MONTHS
THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 39,031,000
<SECURITIES> 0
<RECEIVABLES> 1,418,000
<ALLOWANCES> 0
<INVENTORY> 4,634,000
<CURRENT-ASSETS> 45,491,000
<PP&E> 13,641,000
<DEPRECIATION> 8,950,000
<TOTAL-ASSETS> 52,175,000
<CURRENT-LIABILITIES> 5,786,000
<BONDS> 0
0
0
<COMMON> 18,000
<OTHER-SE> 40,537,000
<TOTAL-LIABILITY-AND-EQUITY> 52,175,000
<SALES> 7,474,000
<TOTAL-REVENUES> 6,190,000
<CGS> 12,007,000
<TOTAL-COSTS> 23,111,000
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 453,000
<INCOME-PRETAX> (17,159,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (17,159,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (17,159,000)
<EPS-BASIC> (1.20)
<EPS-DILUTED> (1.20)
</TABLE>
|
|